Therapeutic advances have considerably improved the recovery of cancer patients. This progress raises the question of the side effects of treatments, particularly widely used cisplatin chemotherapy. This treatment carries risks of deafness and tinnitus. These side effects can be very debilitating for people who have recovered from cancer. Monitoring these adverse effects involves repeated travel to specialized reference centers, as it requires audiometric equipment and audiology knowledge not available in primary care. These difficulties in accessing care represent an inequality of treatment between people living in regions with a high density of doctors versus regions with few services, such as rural areas. This monitoring cannot be carried out routinely for all patients, and preventive or treatment measures are not implemented in a timely manner. Thanks to the deployment of portable solutions on a tablet with active noise-canceling headphones, it is now possible to perform audiometric tests at home, which revolutionizes assistance. The objective of this project is to deploy a monitoring protocol that includes clinical centers throughout the SUDOE region. The consortium will 1/ evaluate a telemedicine protocol to monitor the hearing of patients undergoing chemotherapy at home, 2/ measure its medical-economic impact, 3/ personalize the treatment using artificial intelligence methods, taking into account epidemiological data and genetic predisposition. The design and evaluation of this project can only be conceived on an international scale, as it must adapt to the diversity of healthcare systems, but also to the genetic and cultural diversity of its users. Ultimately, the validation of these solutions will facilitate the prevention of hearing problems in patients undergoing cancer treatment, correcting regional disparities of economic or geographical origin throughout the SUDOE region.